RNAi Technologies Market 2027 By Type, Application | The Insight Partners

RNAi Technologies Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Small interfering RNAi, Micro RNAi); Application (Drug Discovery and Development, Therapeutics, Other Applications)

Report Code: TIPRE00017618 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

RNAi technology is developing as a viable therapeutic platform for the treatment of several diseases. Due to efficient delivery mechanisms, excellent specificity in the targeted section, knockdown approach, and RNAi-based therapies safety. Furthermore, RNAi technology has made each gene in the human genome a druggable target, generating new opportunities for merchants to develop a wide range of targeted therapeutics.

MARKET DYNAMICS

RNAi technologies market is driving due to the increasing adoption of RNAi technology for undruggable targets, recent advances in whole-genome RNAi screening. However, less knowledge of currently available treatment options for RNAi technologies hamper the market's growth. Moreover, the adoption of constant focus on developing RNAi products by key players and advancements in technology and development of new targeted molecules is expected to provide opportunities in the global RNAi technologies market.

MARKET SCOPE

The "RNAi Technologies Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of RNAi technologies market with detailed market segmentation by type and application. The RNAi technologies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in RNAi technologies market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The RNAi technologies market are segmented on the basis of type, and end user. Based on type, the market is segmented small interfering RNAi, micro RNAi Based on application, the market is segmented as drug discovery and development, therapeutics, other applications.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the RNAi technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The RNAi technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting RNAi technologies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the RNAi technologies market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the RNAi technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from RNAi technologies market are anticipated to have lucrative growth opportunities in the future with the rising demand for RNAi technologies in the global market. Below mentioned is the list of few companies engaged in the RNAi technologies market.

The report also includes the profiles of key players in RNAi technologies market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Alnylam Pharmaceuticals
  •   Benitec Biopharma Ltd.
  •   Ionis Pharmaceuticals
  •   Quark Pharmaceuticals Inc.
  •   RXI Pharmaceuticals
  •   QIAGEN
  •   Invitrogen(Thermo Fisher)
  •   FilmTec Corporation
  •   Silence Therapeutics PLC
  •   Arcturus Therapeutics, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 RNAi Technologies Market - By Type
1.3.2 RNAi Technologies Market - By Application
1.3.3 RNAi Technologies Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RNAI TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RNAI TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RNAI TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. RNAI TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. RNAI TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
?
7. RNAI TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SMALL INTERFERING RNAI
7.3.1. Overview
7.3.2. Small interfering RNAi Market Forecast and Analysis
7.4. MICRO RNAI
7.4.1. Overview
7.4.2. Micro RNAi Market Forecast and Analysis
8. RNAI TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY AND DEVELOPMENT
8.3.1. Overview
8.3.2. Drug Discovery and Development Market Forecast and Analysis
8.4. THERAPEUTICS
8.4.1. Overview
8.4.2. Therapeutics Market Forecast and Analysis
8.4.3. Oncology Market
8.4.3.1. Overview
8.4.3.2. Oncology Market Forecast and Analysis
8.4.4. Ocular Disorders Market
8.4.4.1. Overview
8.4.4.2. Ocular Disorders Market Forecast and Analysis
8.4.5. Respiratory Disorders Market
8.4.5.1. Overview
8.4.5.2. Respiratory Disorders Market Forecast and Analysis
8.4.6. Hepatitis B and C Market
8.4.6.1. Overview
8.4.6.2. Hepatitis B and C Market Forecast and Analysis
8.4.7. Autoimmune Hepatitis Market
8.4.7.1. Overview
8.4.7.2. Autoimmune Hepatitis Market Forecast and Analysis
8.4.8. Neurological Disorders Market
8.4.8.1. Overview
8.4.8.2. Neurological Disorders Market Forecast and Analysis
8.4.9. Other Therapeutics Market
8.4.9.1. Overview
8.4.9.2. Other Therapeutics Market Forecast and Analysis
8.5. OTHER APPLICATIONS
8.5.1. Overview
8.5.2. Other Applications Market Forecast and Analysis
9. RNAI TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America RNAi Technologies Market Overview
9.1.2 North America RNAi Technologies Market Forecasts and Analysis
9.1.3 North America RNAi Technologies Market Forecasts and Analysis - By Type
9.1.4 North America RNAi Technologies Market Forecasts and Analysis - By Application
9.1.5 North America RNAi Technologies Market Forecasts and Analysis - By Countries
9.1.5.1 United States RNAi Technologies Market
9.1.5.1.1 United States RNAi Technologies Market by Type
9.1.5.1.2 United States RNAi Technologies Market by Application
9.1.5.2 Canada RNAi Technologies Market
9.1.5.2.1 Canada RNAi Technologies Market by Type
9.1.5.2.2 Canada RNAi Technologies Market by Application
9.1.5.3 Mexico RNAi Technologies Market
9.1.5.3.1 Mexico RNAi Technologies Market by Type
9.1.5.3.2 Mexico RNAi Technologies Market by Application
9.2. EUROPE
9.2.1 Europe RNAi Technologies Market Overview
9.2.2 Europe RNAi Technologies Market Forecasts and Analysis
9.2.3 Europe RNAi Technologies Market Forecasts and Analysis - By Type
9.2.4 Europe RNAi Technologies Market Forecasts and Analysis - By Application
9.2.5 Europe RNAi Technologies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany RNAi Technologies Market
9.2.5.1.1 Germany RNAi Technologies Market by Type
9.2.5.1.2 Germany RNAi Technologies Market by Application
9.2.5.2 France RNAi Technologies Market
9.2.5.2.1 France RNAi Technologies Market by Type
9.2.5.2.2 France RNAi Technologies Market by Application
9.2.5.3 Italy RNAi Technologies Market
9.2.5.3.1 Italy RNAi Technologies Market by Type
9.2.5.3.2 Italy RNAi Technologies Market by Application
9.2.5.4 Spain RNAi Technologies Market
9.2.5.4.1 Spain RNAi Technologies Market by Type
9.2.5.4.2 Spain RNAi Technologies Market by Application
9.2.5.5 United Kingdom RNAi Technologies Market
9.2.5.5.1 United Kingdom RNAi Technologies Market by Type
9.2.5.5.2 United Kingdom RNAi Technologies Market by Application
9.2.5.6 Rest of Europe RNAi Technologies Market
9.2.5.6.1 Rest of Europe RNAi Technologies Market by Type
9.2.5.6.2 Rest of Europe RNAi Technologies Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific RNAi Technologies Market Overview
9.3.2 Asia-Pacific RNAi Technologies Market Forecasts and Analysis
9.3.3 Asia-Pacific RNAi Technologies Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific RNAi Technologies Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific RNAi Technologies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia RNAi Technologies Market
9.3.5.1.1 Australia RNAi Technologies Market by Type
9.3.5.1.2 Australia RNAi Technologies Market by Application
9.3.5.2 China RNAi Technologies Market
9.3.5.2.1 China RNAi Technologies Market by Type
9.3.5.2.2 China RNAi Technologies Market by Application
9.3.5.3 India RNAi Technologies Market
9.3.5.3.1 India RNAi Technologies Market by Type
9.3.5.3.2 India RNAi Technologies Market by Application
9.3.5.4 Japan RNAi Technologies Market
9.3.5.4.1 Japan RNAi Technologies Market by Type
9.3.5.4.2 Japan RNAi Technologies Market by Application
9.3.5.5 South Korea RNAi Technologies Market
9.3.5.5.1 South Korea RNAi Technologies Market by Type
9.3.5.5.2 South Korea RNAi Technologies Market by Application
9.3.5.6 Rest of Asia-Pacific RNAi Technologies Market
9.3.5.6.1 Rest of Asia-Pacific RNAi Technologies Market by Type
9.3.5.6.2 Rest of Asia-Pacific RNAi Technologies Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa RNAi Technologies Market Overview
9.4.2 Middle East and Africa RNAi Technologies Market Forecasts and Analysis
9.4.3 Middle East and Africa RNAi Technologies Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa RNAi Technologies Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa RNAi Technologies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa RNAi Technologies Market
9.4.5.1.1 South Africa RNAi Technologies Market by Type
9.4.5.1.2 South Africa RNAi Technologies Market by Application
9.4.5.2 Saudi Arabia RNAi Technologies Market
9.4.5.2.1 Saudi Arabia RNAi Technologies Market by Type
9.4.5.2.2 Saudi Arabia RNAi Technologies Market by Application
9.4.5.3 U.A.E RNAi Technologies Market
9.4.5.3.1 U.A.E RNAi Technologies Market by Type
9.4.5.3.2 U.A.E RNAi Technologies Market by Application
9.4.5.4 Rest of Middle East and Africa RNAi Technologies Market
9.4.5.4.1 Rest of Middle East and Africa RNAi Technologies Market by Type
9.4.5.4.2 Rest of Middle East and Africa RNAi Technologies Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America RNAi Technologies Market Overview
9.5.2 South and Central America RNAi Technologies Market Forecasts and Analysis
9.5.3 South and Central America RNAi Technologies Market Forecasts and Analysis - By Type
9.5.4 South and Central America RNAi Technologies Market Forecasts and Analysis - By Application
9.5.5 South and Central America RNAi Technologies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil RNAi Technologies Market
9.5.5.1.1 Brazil RNAi Technologies Market by Type
9.5.5.1.2 Brazil RNAi Technologies Market by Application
9.5.5.2 Argentina RNAi Technologies Market
9.5.5.2.1 Argentina RNAi Technologies Market by Type
9.5.5.2.2 Argentina RNAi Technologies Market by Application
9.5.5.3 Rest of South and Central America RNAi Technologies Market
9.5.5.3.1 Rest of South and Central America RNAi Technologies Market by Type
9.5.5.3.2 Rest of South and Central America RNAi Technologies Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RNAI TECHNOLOGIES MARKET
10.1 NORTH AMERICA
10.2 EUROPE
10.3 ASIA-PACIFIC
10.4 MIDDLE EAST AND AFRICA
10.5 SOUTH AND CENTRAL AMERICA
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RNAI TECHNOLOGIES MARKET, KEY COMPANY PROFILES
12.1. ALNYLAM PHARMACEUTICALS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BENITEC BIOPHARMA LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. IONIS PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. QUARK PHARMACEUTICALS INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. RXI PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. QIAGEN
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INVITROGEN(THERMO FISHER)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FILMTEC CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SILENCE THERAPEUTICS PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ARCTURUS THERAPEUTICS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Alnylam Pharmaceuticals
2. Benitec Biopharma Ltd.
3. Ionis Pharmaceuticals
4. Quark Pharmaceuticals Inc.
5. RXI Pharmaceuticals
6. QIAGEN
7. Invitrogen(Thermo Fisher)
8. FilmTec Corporation
9. Silence Therapeutics PLC
10. Arcturus Therapeutics, Inc.
TIPRE00017618
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking